Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 receptor agonists and SGLT2 inhibitors for obesity/overweight in non-diabetic patients
jRCT1051240189Not yet recruiting
- Sponsor
- Osaka Umeda Kenbi Clinic
- Start
- Nov 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in obesity and Overweight, sponsored by Osaka Umeda Kenbi Clinic. Primary endpoints: Body weight change, BMI change and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Conditions
obesityOverweight
Beyond the preview
Go deeper on jRCT1051240189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240189.